1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > General Medicine and Specialty Medicine Analysis & Statistics, March 2016 (p20)

General Medicine and Specialty Medicine Analysis & Statistics, March 2016 (p20)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

All regions

571-600 of about 3 900 reports

Purchase Reports From Reputable Market Research Publishers

Myriad Genetics, Inc. (MYGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Myriad Genetics, Inc. (MYGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary Myriad Genetics, Inc. (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. ...

Ambry Genetics Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Ambry Genetics Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary Ambry Genetics Corp. (Ambry Genetics) is a biotechnology company that provides genetic testing services. The company offers clinical diagnostics services, which include tests, forms, billing, managed ...

  • Industries : General Medicine and Specialty Medicine
Aarhus University Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Aarhus University Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary Aarhus University Hospital (Aarhus), a subsidiary of Aarhus University is a healthcare service provider. The hospital provides patient care, education and research services, abdominal and paediatric ...

  • Industries : General Medicine and Specialty Medicine, Medical Facility, Healthcare
Clovis Oncology, Inc. (CLVS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Clovis Oncology, Inc. (CLVS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary Clovis Oncology, Inc. (Clovis) is a biopharmaceutical company that acquires, develops and commercializes new anti-cancer agents. The company's development programs are targeted at specific cance ...

  • Industries : Pathology
  • Countries : United States
Seattle Genetics, Inc. (SGEN) - Financial and Strategic SWOT Analysis Review

Seattle Genetics, Inc. (SGEN) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • April 2016
  • by Global Data

Seattle Genetics, Inc. (SGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : United States
Cancer Genetics Inc

Cancer Genetics Inc

  • $ 99
  • Company report
  • May 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Cancer Genetics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Healthcare
  • Countries : United States
Newlink Genetics Corporation

Newlink Genetics Corporation

  • $ 99
  • Company report
  • May 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Newlink Genetics Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Myriad Genetics Inc

Myriad Genetics Inc

  • $ 99
  • Company report
  • May 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Myriad Genetics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : General Medicine and Specialty Medicine, Hospitality, Hospitality
  • Countries : United States
Erectile Dysfunction - Pipeline Review, H1 2016

Erectile Dysfunction - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • February 2016
  • by Global Markets Direct

Erectile Dysfunction - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Erectile Dysfunction - Pipeline Review, H1 2016’, provides an overview of the Erectile Dysfunction pipeline landscape. ...

  • Industries : General Medicine and Specialty Medicine, Healthcare, Pharmaceutical, Pathology
  • Countries : United States
Indolent Lymphoma - Pipeline Review, H1 2016

Indolent Lymphoma - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • February 2016
  • by Global Markets Direct

Indolent Lymphoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Indolent Lymphoma pipeline landscape. The ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2016

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • February 2016
  • by Global Markets Direct

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2016’, provides an overview of the B-Cell ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Autism - Pipeline Review, H1 2016

Autism - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • February 2016
  • by Global Markets Direct

Autism - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Autism - Pipeline Review, H1 2016’, provides an overview of the Autism pipeline landscape. The report provides comprehensive information ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Thelial Technologies S.A. - Product Pipeline Review - 2016

Thelial Technologies S.A. - Product Pipeline Review - 2016

  • $ 1 500
  • Industry report
  • February 2016
  • by Global Markets Direct

Thelial Technologies S.A. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Thelial Technologies S.A. - Product Pipeline Review - 2016’, provides an overview of the Thelial Technologies ...

  • Industries : Research and Development
  • Countries : World
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2016

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • February 2016
  • by Global Markets Direct

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2016’, provides ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Sutro Biopharma, Inc. - Product Pipeline Review - 2016

Sutro Biopharma, Inc. - Product Pipeline Review - 2016

  • $ 1 500
  • Industry report
  • February 2016
  • by Global Markets Direct

Sutro Biopharma, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Sutro Biopharma, Inc. - Product Pipeline Review - 2016’, provides an overview of the Sutro Biopharma, Inc.’s ...

  • Industries : Biopharmaceutical, Research and Development
  • Countries : United States
Mantle Cell Lymphoma - Pipeline Review, H1 2016

Mantle Cell Lymphoma - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • February 2016
  • by Global Markets Direct

Mantle Cell Lymphoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Mantle Cell Lymphoma pipeline landscape. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Hodgkin Lymphoma - Pipeline Review, H1 2016

Hodgkin Lymphoma - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • February 2016
  • by Global Markets Direct

Hodgkin Lymphoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Hodgkin Lymphoma pipeline landscape. The report ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Strabismus Global Clinical Trials Review, H1, 2016

Strabismus Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Company report
  • February 2016
  • by Global Data

Strabismus Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Strabismus Global Clinical Trials Review, H1, 2016" provides an overview of Strabismus clinical trials ...

  • Industries : Pathology, Pharmaceutical
  • Countries : World
Blepharitis Global Clinical Trials Review, H1, 2016

Blepharitis Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Company report
  • February 2016
  • by Global Data

Blepharitis Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Blepharitis Global Clinical Trials Review, H1, 2016" provides an overview of Blepharitis clinical trials ...

  • Industries : Pathology, Pharmaceutical
  • Countries : World
Dental Pain Global Clinical Trials Review, H1, 2016

Dental Pain Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Company report
  • February 2016
  • by Global Data

Dental Pain Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Dental Pain Global Clinical Trials Review, H1, 2016" provides an overview of Dental Pain clinical trials ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Drug and Medication
  • Countries : World
Tumor Ablation Market Size & Forecast By Technology (Radiofrequency, Microwave, Cryoablation), By Treatment (Surgical, Laparoscopic, Percutaneous) By Application (Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Cancer), And Trend Analysis From 2015 To

Tumor Ablation Market Size & Forecast By Technology (Radiofrequency, Microwave, Cryoablation), By Treatment (Surgical, Laparoscopic, Percutaneous) By Application (Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Cancer), And Trend Analysis From 2015 To

  • $ 4 700
  • Industry report
  • February 2016
  • by Grand View Research

Global tumor ablation market is expected to reach USD 1.5 billion by 2022, according to a new study by Grand View Research Inc. Rising prevalence of different forms of cancer and increasing technological ...

  • Industries : General Medicine and Specialty Medicine
Response Genetics, Inc. (RGDX) - Medical Equipment - Deals and Alliances Profile

Response Genetics, Inc. (RGDX) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2016
  • by Global Data

Summary Response Genetics, Inc. (RGI) is a molecular diagnostics company that research and develops clinical diagnostic tests for cancer to physicians and patients. The company offers tests and panels ...

  • Industries : General Medicine and Specialty Medicine
University Hospitals Case Medical Center - Medical Equipment - Deals and Alliances Profile

University Hospitals Case Medical Center - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2016
  • by Global Data

Summary University Hospitals Case Medical Center (UHCMC) is a non-profit academic medical center that provides adult and pediatric medical services, clinical research services and educational services. ...

  • Industries : General Medicine and Specialty Medicine, Medical Facility, Healthcare
  • Countries : United States
Signal Genetics, Inc. (SGNL) - Medical Equipment - Deals and Alliances Profile

Signal Genetics, Inc. (SGNL) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2016
  • by Global Data

Summary Signal Genetics, Inc. (Signal Genetics) is a molecular diagnostic company that provides diagnostic services. The company's Myeloma Prognostic Risk Signature test is a microarray-based gene expression ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : United States
Vision Eye Institute Limited (VEI) - Medical Equipment - Deals and Alliances Profile

Vision Eye Institute Limited (VEI) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2016
  • by Global Data

Summary Vision Eye Institute Limited (Vision) is a healthcare service provider that offers ophthalmic care services. The center provides medical services in laser eye surgery, cataract surgery, glaucoma, ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : Australia
Global Contact Lenses & Intraocular Lenses Market Assessment & Forecast: 2015-2019

Global Contact Lenses & Intraocular Lenses Market Assessment & Forecast: 2015-2019

  • $ 3 500
  • Industry report
  • February 2016
  • by Spearhead Acuity

According to the new report “Global Contact Lenses & Intraocular Lenses Market Assessment & Forecast 2015 - 2019” by SA-Business Research & Consulting Group, Middle-East and Asia-Pacific regions are ...

  • Industries : Ophthalmic Devices, Medical Devices, General Medicine and Specialty Medicine
  • Countries : World
Ipsen S.A. - Strategy and SWOT Report

Ipsen S.A. - Strategy and SWOT Report

  • $ 175
  • Company report
  • February 2016
  • by MarketLine

Ipsen S.A. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and ...

  • Industries : Pathology
  • Countries : Europe, United States, World
Regurgitation Global Clinical Trials Review, H1, 2016

Regurgitation Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Company report
  • February 2016
  • by Global Data

Regurgitation Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Regurgitation Global Clinical Trials Review, H1, 2016" provides an overview of Regurgitation clinical ...

  • Industries : Pharmaceutical, Drug and Medication, Pathology, Therapy
  • Countries : World
Osteoarthritis Global Clinical Trials Review, H1, 2016

Osteoarthritis Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Company report
  • February 2016
  • by Global Data

Osteoarthritis Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Osteoarthritis Global Clinical Trials Review, H1, 2016" provides an overview of Osteoarthritis clinical ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Venous Thromboembolism Global Clinical Trials Review, H1, 2016

Venous Thromboembolism Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Company report
  • February 2016
  • by Global Data

Venous Thromboembolism Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H1, 2016" provides an overview of Venous ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.